In Silico Application (ISA) Working Group
Digital evidence can and must be used for regulatory approval in all parts of the world. The Research & Technology Working Group has made huge progress, which now allows to start applying modeling and simulation, as properly defined, to accelerate medical innovation access to patients.
Many organizations are willing to invest in in silico but practical implementation guidance is needed:
- How can I scale up my pharmaceutical process to produce medicine for the next approval phase?
- How can I actually bring in silico to the hospital daily activities and the patients?
- How can I deploy in silico methods as part of my regulatory approval process?
The new Avicenna In Silico Application Working Group, led by Cecile Rousseau, PhD (VCLS) and Emmanuelle Voisin, PhD (VCLS), aims to deploy In Silico methods downstream and design comprehensive solutions (process, access to research, software, hardware, humanware, possibly services) to allow any organization to time and cost effectively adopt and deploy in silico methods all along the development, registration and life cycle of the products.